BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 2717521)

  • 1. Pharmacokinetics of ketorolac and p-hydroxyketorolac following oral and intramuscular administration of ketorolac tromethamine.
    Jung D; Mroszczak EJ; Wu A; Ling TL; Sevelius H; Bynum L
    Pharm Res; 1989 Jan; 6(1):62-5. PubMed ID: 2717521
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Ketorolac tromethamine absorption, distribution, metabolism, excretion, and pharmacokinetics in animals and humans.
    Mroszczak EJ; Lee FW; Combs D; Sarnquist FH; Huang BL; Wu AT; Tokes LG; Maddox ML; Cho DK
    Drug Metab Dispos; 1987; 15(5):618-26. PubMed ID: 2891477
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pharmacokinetics of single-dose oral and intramuscular ketorolac tromethamine in the young and elderly.
    Jallad NS; Garg DC; Martinez JJ; Mroszczak EJ; Weidler DJ
    J Clin Pharmacol; 1990 Jan; 30(1):76-81. PubMed ID: 2303585
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pharmacokinetics of ketorolac tromethamine in humans after intravenous, intramuscular and oral administration.
    Jung D; Mroszczak E; Bynum L
    Eur J Clin Pharmacol; 1988; 35(4):423-5. PubMed ID: 3264245
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Ketorolac tromethamine pharmacokinetics and metabolism after intravenous, intramuscular, and oral administration in humans and animals.
    Mroszczak EJ; Jung D; Yee J; Bynum L; Sevelius H; Massey I
    Pharmacotherapy; 1990; 10(6 ( Pt 2)):33S-39S. PubMed ID: 2082311
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Ocular bioavailability and tissue distribution of [14C]ketorolac tromethamine in rabbits.
    Ling TL; Combs DL
    J Pharm Sci; 1987 Apr; 76(4):289-94. PubMed ID: 3598886
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The excretion of ketorolac tromethamine into breast milk after multiple oral dosing.
    Wischnik A; Manth SM; Lloyd J; Bullingham R; Thompson JS
    Eur J Clin Pharmacol; 1989; 36(5):521-4. PubMed ID: 2787750
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparative bioavailability of two oral formulations of ketorolac tromethamine: Dolac and Exodol.
    Flores-Murrieta FJ; Granados-Soto V; Castañeda-Hernández G; Herrera JE; Hong E
    Biopharm Drug Dispos; 1994 Mar; 15(2):129-36. PubMed ID: 8011965
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The pharmacokinetics of ketorolac enantiomers following intramuscular administration of the racemate.
    Hayball PJ; Wrobel J; Tamblyn JG; Nation RL
    Br J Clin Pharmacol; 1994 Jan; 37(1):75-8. PubMed ID: 8148223
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The use of ketorolac in the management of postoperative pain.
    DeAndrade JR; Maslanka M; Maneatis T; Bynum L; Burchmore M
    Orthopedics; 1994 Feb; 17(2):157-66. PubMed ID: 8190679
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Ketorolac tromethamine.
    Med Lett Drugs Ther; 1990 Aug; 32(825):79-81. PubMed ID: 2199809
    [No Abstract]   [Full Text] [Related]  

  • 12. Clinical pharmacokinetics of ketorolac tromethamine.
    Brocks DR; Jamali F
    Clin Pharmacokinet; 1992 Dec; 23(6):415-27. PubMed ID: 1458761
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pharmacokinetics of oral ketorolac in the rat.
    Granados-Soto V; Flores-Murrieta FJ
    Methods Find Exp Clin Pharmacol; 1995 Oct; 17(8):535-8. PubMed ID: 8749226
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The analgesic and anti-inflammatory profile of ketorolac and its tromethamine salt.
    Rooks WH; Maloney PJ; Shott LD; Schuler ME; Sevelius H; Strosberg AM; Tanenbaum L; Tomolonis AJ; Wallach MB; Waterbury D
    Drugs Exp Clin Res; 1985; 11(8):479-92. PubMed ID: 3879752
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Tolerability, central effects and pharmacokinetics of intravenous ketorolac tromethamine in volunteers.
    Lucker P; Bullingham R; Hooftman L; Lloyd J; Mroszczak E
    Int J Clin Pharmacol Ther; 1994 Aug; 32(8):409-14. PubMed ID: 7981925
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Ketorolac: a parenteral nonsteroidal antiinflammatory drug.
    Resman-Targoff BH
    DICP; 1990 Nov; 24(11):1098-104. PubMed ID: 2275236
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A double-blind study with placebo control of intramuscular ketorolac tromethamine in the treatment of cancer pain.
    Staquet MJ
    J Clin Pharmacol; 1989 Nov; 29(11):1031-6. PubMed ID: 2689472
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Nasal formulations of ketorolac tromethamine: technological evaluation--bioavailability and tolerability in rabbits.
    Santus G; Rivolta R; Bottoni G; Testa B; Canali S; Peano S
    Farmaco; 1993 Dec; 48(12):1709-23. PubMed ID: 8135994
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A double-blind study of the speed of onset of analgesia following intramuscular administration of ketorolac tromethamine in comparison to intramuscular morphine and placebo.
    Rice AS; Lloyd J; Miller CG; Bullingham RE; O'sullivan GM
    Anaesthesia; 1991 Jul; 46(7):541-4. PubMed ID: 1862891
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Analgesic efficacy and safety of single-dose oral and intramuscular ketorolac tromethamine for postoperative pain.
    Brown CR; Moodie JE; Dickie G; Wild VM; Smith BA; Clarke PJ; Evans SA; Bynum LJ
    Pharmacotherapy; 1990; 10(6 ( Pt 2)):59S-70S. PubMed ID: 2082315
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.